477 related articles for article (PubMed ID: 11459780)
21. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
Spitzweg C; Joba W; Morris JC; Heufelder AE
Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
[TBL] [Abstract][Full Text] [Related]
22. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
[TBL] [Abstract][Full Text] [Related]
23. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
[TBL] [Abstract][Full Text] [Related]
24. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
Xu J; Hershman JM
Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
[TBL] [Abstract][Full Text] [Related]
26. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
Shimura H; Haraguchi K; Miyazaki A; Endo T; Onaya T
Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
[TBL] [Abstract][Full Text] [Related]
27. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
Li W; Venkataraman GM; Ain KB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1080-7. PubMed ID: 17164311
[TBL] [Abstract][Full Text] [Related]
28. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.
Ros P; Rossi DL; Acebrón A; Santisteban P
Biochimie; 1999 Apr; 81(4):389-96. PubMed ID: 10401674
[TBL] [Abstract][Full Text] [Related]
31. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
[TBL] [Abstract][Full Text] [Related]
33. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
[TBL] [Abstract][Full Text] [Related]
35. Expression of sodium-iodide symporter mRNA in the thyroid gland of Xenopus laevis tadpoles: developmental expression, effects of antithyroidal compounds, and regulation by TSH.
Opitz R; Trubiroha A; Lorenz C; Lutz I; Hartmann S; Blank T; Braunbeck T; Kloas W
J Endocrinol; 2006 Jul; 190(1):157-70. PubMed ID: 16837620
[TBL] [Abstract][Full Text] [Related]
36. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
37. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
38. Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake.
Altmann A; Schulz RB; Glensch G; Eskerski H; Zitzmann S; Eisenhut M; Haberkorn U
J Nucl Med; 2005 May; 46(5):831-9. PubMed ID: 15872358
[TBL] [Abstract][Full Text] [Related]
39. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
[TBL] [Abstract][Full Text] [Related]
40. Promoter characterization of the human Na+/I- symporter.
Ryu KY; Tong Q; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3247-51. PubMed ID: 9745437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
